MEDIPATH FRANCE logo — DIAGNOSTIC ET EXPERTISE DE PROXIMITE EN CANCEROLOGIE

MEDIPATH FRANCE

DIAGNOSTIC ET EXPERTISE DE PROXIMITE EN CANCEROLOGIE

Founded 1999 France France 379 employees Health Care

General Information

Company Name MEDIPATH FRANCE
Founded Year 1999
Location France France
Employees 379
Industries Health Care
Social

BounceWatch is an independent company data service, not affiliated with MEDIPATH FRANCE. To contact MEDIPATH FRANCE, visit medipath.fr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MEDIPATH FRANCE compare?

A PDF of MEDIPATH FRANCE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MEDIPATH FRANCE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MEDIPATH FRANCE

MEDIPATH FRANCE is a leading player in France in the field of health care, specifically in cancer diagnostics and expertise. With over 25 years of experience, the company continues to prioritize public health by maintaining close relationships with clinicians. Governed by pathologist physicians, MEDIPATH's primary goal is to uphold a high level of expertise and quality while actively participating in the fight against cancer through top-notch services. MEDIPATH boasts a team of over 120 physicians, including 12 reference pathologist physicians in national networks of rare pathology expertise at the National Cancer Institute (INCa), and 12 molecular pathologists distributed across 33 geographical centers, along with more than 700 employees. This places the company as a major player in anatomical pathology, collaborating with over 250 healthcare institutions and handling over 1.5 million case files annually10% of cancer diagnoses in France. Furthermore, MEDIPATH is at the forefront of quality initiatives, accrediting its technical platforms and medical-administrative sites. Their general and molecular pathology platforms are accredited to conduct necessary molecular tests for targeted therapies such as KRAS and BRAF. Integrating Artificial Intelligence into cancer screening and diagnosis, the company combines medical expertise with technological advancements, paving the way for early detection and personalized patient care. Their AI tools, including Galen™ Prostate, Galen™ Breast, VisioCyt® Bladder, and Genius™ Digital Diagnostic, provide valuable support to pathologist physicians in diagnosing prostate, breast, bladder, and cervical cancer, offering a second opinion. These innovations represent a significant, powerful, and highly effective advancement in cancer diagnostics.

Business keywords: cancer diagnostics, anatomical pathology, molecular pathology, medical expertise, accreditation, proximity healthcare, quality assurance, artificial intelligence in healthcare, early cancer detection, personalized medicine, oncology expertise

No funding data available for MEDIPATH FRANCE yet.

MEDIPATH FRANCE Alternatives & Competitors

View All Alternatives
MEDIPATH FRANCE vs

Laboratoire de biologie médicale indépendant dont l’expertise et le savoir-faire reposent sur + de 6...

100 employees
Biotechnology, Health Care
MEDIPATH FRANCE vs

Innovative Solutions for Cancer Diagnostics

Series A
6 employees
Biotechnology, Health Care
MEDIPATH FRANCE vs

Service, Integrity, and Innovation

321 employees
Health Care

FAQ About MEDIPATH FRANCE

DIAGNOSTIC ET EXPERTISE DE PROXIMITE EN CANCEROLOGIE
MEDIPATH FRANCE was founded in 1999.
MEDIPATH FRANCE is headquartered in France.
MEDIPATH FRANCE operates in Health Care. Its work centres on cancer diagnostics, anatomical pathology, molecular pathology and medical expertise.
MEDIPATH FRANCE has approximately 379 employees.
Top alternatives and competitors to MEDIPATH FRANCE include Laboratoires Reunis, OncoDiag, sïParadigm Diagnostic Informatics, Proteocyte AI, JaxBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MEDIPATH FRANCE and Laboratoires Reunis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MEDIPATH FRANCE, https://bouncewatch.com/company/medipath, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes